| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.81▼ | 12.80▼ | 12.78▲ | 12.54▲ | 12.25▲ |
| MA10 | 12.80▲ | 12.79▲ | 12.72▲ | 12.37▲ | 11.86▲ |
| MA20 | 12.79▲ | 12.70▲ | 12.60▲ | 12.17▲ | 12.03▲ |
| MA50 | 12.71▲ | 12.52▲ | 12.43▲ | 11.77▲ | 11.16▲ |
| MA100 | 12.59▲ | 12.39▲ | 12.17▲ | 12.07▲ | 10.54▲ |
| MA200 | 12.46▲ | 12.07▲ | 11.85▲ | 11.36▲ | 9.98▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.001▼ | 0.016▲ | 0.062▲ | 0.051▲ |
| RSI | 59.221▲ | 70.540▲ | 72.059▲ | 68.990▲ | 60.790▲ |
| STOCH | 76.984 | 69.929 | 81.859▲ | 88.889▲ | 73.881 |
| WILL %R | -28.571 | -18.750▲ | -11.111▲ | -3.226▲ | -2.639▲ |
| CCI | 41.759 | 49.166 | 85.027 | 164.797▲ | 180.262▲ |
|
Thursday, September 18, 2025 06:15 AM
Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicines Members leverage AI-powered dataset to accelerate pharma R&D ...
|
|
Thursday, July 10, 2025 02:17 PM
PHILADELPHIA, July 10, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, THQ, THW and NYSE American: FAX, FCO, VFL), announced today that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/01/26 | 12.845 | 12.845 | 12.75 | 12.80 | 142,865 |
| 21/01/26 | 12.56 | 12.74 | 12.50 | 12.70 | 165,968 |
| 20/01/26 | 12.33 | 12.55 | 12.32 | 12.47 | 209,347 |
| 16/01/26 | 12.39 | 12.49 | 12.26 | 12.49 | 147,161 |
| 15/01/26 | 12.44 | 12.55 | 12.25 | 12.25 | 172,300 |
| 14/01/26 | 12.33 | 12.39 | 12.2719 | 12.38 | 104,378 |
| 13/01/26 | 12.21 | 12.34 | 12.1001 | 12.34 | 112,309 |
| 12/01/26 | 12.20 | 12.34 | 11.99 | 12.16 | 221,296 |
| 09/01/26 | 12.05 | 12.31 | 12.00 | 12.20 | 146,900 |
| 08/01/26 | 12.26 | 12.28 | 11.87 | 11.95 | 209,700 |
|
|
||||
|
|
||||
|
|